TIDMDXRX

RNS Number : 7394D

Diaceutics PLC

01 July 2021

1 July 2021

Diaceutics PLC

("Diaceutics" or "the Company")

Issue of Share Options and PDMR Shareholdings

Diaceutics PLC , ( AIM: DXRX), the diagnostic commercialisation company for precision testing announces the issue of share options over ordinary shares of GBP0.002 each in the Company ("Share Options") on 30 June 2021, to certain members of the Company's senior management team and other key staff. These share options have been issued pursuant to certain contractual share-based entitlements in place prior to the Company's IPO and are governed by the rules of the Company's Employee Share Option Plan ("ESOP").

Share Options were granted as follows:

 
 Name                     Number of Share  Total no. of ordinary  % of existing 
                          Options granted    shares under option   issued share 
                                                      post grant        capital 
 Damian Thornton (COO 
  and PDMR)                         4,200                170,996           0.2% 
                         ----------------  ---------------------  ------------- 
 Susanne Munksted (CPO 
  and PDMR)                         4,200                 70,672          0.08% 
                         ----------------  ---------------------  ------------- 
 

A further 147,000 Share Options were granted to 35 employees, each of whom received 4,200 Share Options.

The Share Options vest in full after three years following date of grant subject to the grantee receiving no more than two "unsatisfactory" performance ratings in their individual performance reviews in the three-year period from the date of grant. The exercise price of the Share Options is GBP0.002 per share being the nominal value of the share.

Following the grant the total number of share options outstanding granted to the Company's Directors, senior management team and key employees is 2,237,170, representing approximately 2.7% of the Company's current issued share capital of 84,068,923.

Enquiries:

 
 Diaceutics PLC 
Philip White, Chief Financial Officer                        Via Alma PR 
 
Stifel Nicolaus Europe Limited (Nomad & Broker)      Tel: +44 (0)20 7710 
                                                                    7600 
Ben Maddison 
Stewart Wallace 
Nick Adams 
 
Alma PR                                               Tel: +44(0)20 3405 
                                                                    0205 
Caroline Forde                                   diaceutics@almapr.co.uk 
Robyn Fisher 
Kieran Breheny 
 

About Diaceutics

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world's leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network(R).

DXRX is the world's first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
------  -------------------------------------------------------------------------------------- 
 a.      Name                                        Damian Thornton 
                                                    ------------------------------------------ 
 2       Reason for notification 
        ------------------------------------------  ------------------------------------------ 
 a.      Position/Status                             Chief Operating Officer 
        ------------------------------------------  ------------------------------------------ 
 b.      Initial notification/                       Initial 
          Amendment 
                                                    ------------------------------------------ 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
 a.      Name                                        Diaceutics PLC 
        ------------------------------------------ 
 b.      LEI                                         213800VEWQBB39ZB8J81 
        ------------------------------------------  ------------------------------------------ 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
------  -------------------------------------------------------------------------------------- 
 a.      Description of                              Ordinary shares of GBP 0.002 each 
          the financial 
          instrument, type                            ISIN: GB00BJQTGV64 
          of instrument 
 
          Identification 
          Code 
        ------------------------------------------  ------------------------------------------ 
 b.      Nature of the                               Grant of Share Options 
          transaction 
        ------------------------------------------  ------------------------------------------ 
 
 c.      Price(s) and volume(s)                       Price(s)            Volume(s) 
        ------------------------------------------   ------------------ 
    GBP0.002                                                              4,200 
   --------------------------------------------------------------------  ----------------- 
 
 d.      Date of the transaction                     30 June 2021 
        ------------------------------------------  ------------------------------------------ 
 e.      Place of the transaction                    Outside a Trading Venue 
        ------------------------------------------  ------------------------------------------ 
 
 
 Notification of a Transaction pursuant to Article 19(1) of Regulation 
  (EU) No. 596/2014 
 1       Details of the person discharging managerial responsibilities/person 
          closely associated 
------  -------------------------------------------------------------------------------------- 
 a.      Name                                        Susanne Munksted 
                                                    ------------------------------------------ 
 2       Reason for notification 
        ------------------------------------------  ------------------------------------------ 
 a.      Position/Status                             Chief Precision Officer 
        ------------------------------------------  ------------------------------------------ 
 b.      Initial notification/                       Initial 
          Amendment 
                                                    ------------------------------------------ 
 3       Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
 a.      Name                                        Diaceutics PLC 
        ------------------------------------------ 
 b.      LEI                                         213800VEWQBB39ZB8J81 
        ------------------------------------------  ------------------------------------------ 
 4       Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
------  -------------------------------------------------------------------------------------- 
 a.      Description of                              Ordinary shares of GBP 0.002 each 
          the financial 
          instrument, type                            ISIN: GB00BJQTGV64 
          of instrument 
 
          Identification 
          Code 
        ------------------------------------------  ------------------------------------------ 
 b.      Nature of the                               Grant of Share Options 
          transaction 
        ------------------------------------------  ------------------------------------------ 
 
 c.      Price(s) and volume(s)                       Price(s)            Volume(s) 
        ------------------------------------------   ------------------ 
    GBP0.002                                                              4,200 
   --------------------------------------------------------------------  ----------------- 
 
 d.      Date of the transaction                     30 June 2021 
        ------------------------------------------  ------------------------------------------ 
 e.      Place of the transaction                    Outside a Trading Venue 
        ------------------------------------------  ------------------------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEAKKEDSKFEFA

(END) Dow Jones Newswires

July 01, 2021 02:00 ET (06:00 GMT)

Diaceutics (LSE:DXRX)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Diaceutics.
Diaceutics (LSE:DXRX)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Diaceutics.